Trial Profile
Phase II, randomised, placebo-controlled, double-blind, dose-response study of collagenase clostridium histolyticum in patients with frozen shoulder [adhesive capsulitis]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2013
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Frozen shoulder
- Focus Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 05 Apr 2013 New trial record
- 26 Mar 2013 Results published in a BioSpecifics Technologies Corporation media release.